BioArctic AB (BRCTF)
33.56
+1.78
(+5.62%)
USD |
OTCM |
Aug 27, 16:00
BioArctic Net Income (Quarterly) : -1.193M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.193M |
| March 31, 2026 | 23.24M |
| December 31, 2025 | -0.9385M |
| September 30, 2025 | -9.128M |
| June 30, 2025 | 9.988M |
| March 31, 2025 | 95.70M |
| December 31, 2024 | -2.918M |
| September 30, 2024 | -1.884M |
| June 30, 2024 | -6.401M |
| March 31, 2024 | -5.537M |
| December 31, 2023 | -8.178M |
| September 30, 2023 | 11.56M |
| June 30, 2023 | -9.706M |
| March 31, 2023 | 28.15M |
| December 31, 2022 | -5.396M |
| September 30, 2022 | 12.96M |
| June 30, 2022 | -4.654M |
| March 31, 2022 | -4.738M |
| December 31, 2021 | -2.139M |
| September 30, 2021 | -4.345M |
| Date | Value |
|---|---|
| June 30, 2021 | -4.063M |
| March 31, 2021 | -3.462M |
| December 31, 2020 | -1.533M |
| September 30, 2020 | -2.329M |
| June 30, 2020 | -3.950M |
| March 31, 2020 | 0.3671M |
| December 31, 2019 | -1.778M |
| September 30, 2019 | -0.8688M |
| June 30, 2019 | 10.61M |
| March 31, 2019 | 1.485M |
| December 31, 2018 | 37.06M |
| September 30, 2018 | 2.890M |
| June 30, 2018 | 0.5899M |
| March 31, 2018 | 1.900M |
| December 31, 2017 | 1.423M |
| September 30, 2017 | -0.0143M |
| June 30, 2017 | 0.2638M |
| December 31, 2016 | 8.280M |
| September 30, 2016 | -0.9104M |
| June 30, 2016 | -1.058M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hansa Biopharma AB | -27.82M |
| Swedish Orphan Biovitrum AB | 117.25M |
| Diamyd Medical AB | -13.67M |
| BONESUPPORT HOLDING AB | 8.743M |
| BioInvent International AB | -13.12M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 26.43M |
| Total Expenses (Quarterly) | 27.63M |
| EPS Diluted (Quarterly) | -0.0134 |
| Enterprise Value | 2.782B |
| Gross Profit Margin (Quarterly) | 91.24% |
| Profit Margin (Quarterly) | -4.51% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 0.82% |
| Normalized Earnings Yield | 0.4004 |